Diagnostic Imaging sat down with medical physicist and CT expert Cynthia H. McCollough, PhD, to learn more about the history of CT and its expanding potential in medical imaging.
Despite what has already been an illustrious career in health care, now is not the time to sleep on computed tomography (CT). Fifty years in, CT remains a cornerstone of medical imaging, aiding not only in diagnosis of disease or trauma, but also in helping to plan and guide therapeutic interventions as well as monitor their outcomes.
Withstanding the test of time and new technology, CT has also weathered bouts of criticism over the years. Although questions about overuse and radiation dose exposure have at times hindered its role, the risk/benefit ratio conversation nearly always tips towards the benefits of the modality, with its ability to quickly answer questions that might otherwise lead providers and patients down a road filled with a multitude of less specific—and so-called less ‘risky’—tests.
To help address some of these questions and improve education around dose, the American Association of Physicists in Medicine (AAPM) in 2010 formed the Alliance for Quality Computed Tomography, which provides several educational and informational resources, including a CT Dose-Check, up-to-date CT imaging protocols for both adult and pediatric patients, as well as CT dose and automatic exposure control educational materials.
To learn more about the history of CT and how to optimize its current use, Diagnostic Imaging spoke with Cynthia H. McCollough, PhD, Brooks-Hollern Professor and professor of medical physics and biomedical engineering at Mayo Clinic. McCollough, who is also director, CT Clinical Innovation Center and X-ray Imaging Core, discussed how CT is currently utilized and highlighted the many ways we can optimize its use in different clinical scenarios, especially when taking into account the technology that allows us to personalize the experience for each patient.
In further commemoration of the anniversary, McCollough helped to put together an online gallery through the AAPM that illustrates the amazing history of CT. View the gallery here.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.